Mark Cuban Cost Plus Drugs (MCCPDC) Review for Telehealth CEOs: Transparent Generic Pricing You Can Build Around
What Cost Plus Drugs is
Cost Plus Drugs is a mail-order pharmacy with radical price transparency: manufacturer cost + 15% markup + pharmacy labor + shipping. It sells (mostly) generics direct-to-consumer and is expanding payer/PBM connectivity. Great for cash-pay or limited-coverage patients—and as a low-cost option in your telemed checkout.
Where it fits in a telehealth stack
- Use cases: Chronic generics (metformin, bupropion, etc.), price-sensitive patients, transparent formulary alternatives.
- Benefit design: Growing list of accepted plans/PBMs; still not universal.
- Employer programs: Active partnerships (e.g., 9amHealth obesity/chronic care) point to B2B traction.
Compliance & operations
- Operates as an online pharmacy, fulfills via HealthDyne; standard pharmacy counseling available.
Strengths
- Radical transparency → easy to communicate to patients/employers.
- Compelling generic pricing → reduces abandonment for cost-sensitive cohorts.
- Momentum with plan sponsors → list of accepted PBMs/insurers keeps growing.
Weaknesses
- Limited formularies vs full-line retail; branded drugs often absent.
- Insurance acceptance not universal (improving but variable).
- No specialty hub functions (PAs/bridge/copay)—pair with a hub (e.g., PhilRx) when needed.
Integrations snapshot
- Provider → Cost Plus: “Contact your doctor” flow, eRx to partner pharmacy; straightforward to embed as a checkout option or “Compare prices” button.
- Employers: Direct partnerships and PBM alignments (AffirmedRx, RxPreferred, etc.).
Pricing & unit economics
Transparent cost model makes it simple to model adherence improvements and reduce CAC waste from sticker shock. For DTC telemed, offering Cost Plus as a cash-pay fallback preserves conversions when insurance blocks the path.
Best for / not for
- Best for: Telemed clinics with substantial generic volume; employer-sponsored programs seeking predictable costs.
- Not for: Brands requiring copay/bridge/PAP, or complex prior-auth journeys.
CEO / investor lens
- Defensible: “We added a transparent, low-cost generic channel—abandonment dropped.”
- Moat: “We route by payer: specialty via hub; generics via transparent cash—maximizes adherence and revenue integrity.”
Verdict
Think of Cost Plus as a pricing rail you can build into the front-end of your pharmacy flow—great for cash and generic strategies; pair with a hub for branded/specialty.
FAQ (Cost Plus Drugs)
How does Cost Plus price meds? Manufacturer cost + 15% markup + labor + shipping.
Does it take insurance? Some PBMs/insurers yes; list is expanding.
Is it suitable for branded/specialty? Generally no—use a hub/specialty channel for those.
